CIViC
Compass
Tumors
Genes
Variants
Evidence
Assertions
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home
/
Biomarker
VHL mutation / loss
Gene:
VHL
· Type:
mutation
Indications: Renal cell carcinoma, VHL disease
Sensitivity
Resistance
CIViC Context
FDA Resistance Assertions
No resistance assertions.